Bronte M. Verhoeven
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma.
Journal: Journal for immunotherapy of cancer
Published: October 21, 2025
Genomic tumor evolution dictates human medulloblastoma progression.
Journal: Neuro-oncology advances
Published: December 11, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.
Journal: Cancer research communications
Published: June 20, 2024
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
Journal: JCI insight
Published: June 22, 2023
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy.
Journal: Oncoimmunology
Published: March 06, 2023
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.
Journal: Cancer cell
Published: February 15, 2023
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.
Journal: Nature communications
Published: April 15, 2022
The immune cell atlas of human neuroblastoma.
Journal: Cell reports. Medicine
Published: November 07, 2021
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026